AK
Ashish Kantilal Shah
About Ashish Kantilal Shah
Data last updated:
Ashish Kantilal Shah has 13 years in corporate governance. Holds Director role. Currently with 2 companies, including R.S. Surgipharm Private Limited and Sarone Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is R.S. Surgipharm Private Limited at ₹134 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 R.S. Surgipharm Private Limited U24230GJ2013PTC074294 | Director | 02 Apr 2013 | 2013 | ₹134 Cr (FY 2025) | Active |
 Sarone Pharmaceuticals Private Limited U46497GJ2023PTC146504 | Director | 13 Mar 2024 | 2023 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ashish Kantilal Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ashish Kantilal Shah
Ashish Kantilal Shah has 13 years in corporate governance. Holds Director role. Currently with 2 companies, including R.S. Surgipharm Private Limited and Sarone Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is R.S. Surgipharm Private Limited at ₹134 Cr (FY 2025).
Ashish Kantilal Shah is associated with 2 companies as Director, including R.S. Surgipharm Private Limited (₹134 Cr), Sarone Pharmaceuticals Private Limited.
Ashish Kantilal Shah has expertise in General Business.
Ashish Kantilal Shah has 13 years in corporate governance.
By reported revenue, the largest current company of Ashish Kantilal Shah is R.S. Surgipharm Private Limited, with revenue of ₹134 Cr (FY 2025).
Ashish Kantilal Shah currently holds positions at 2 companies: R.S. Surgipharm Private Limited (₹134 Cr), Sarone Pharmaceuticals Private Limited.